Gilead Sciences (GILD, Financial) recently declared a steady quarterly dividend of $0.79 per share, keeping its forward yield at 2.98%. This dividend will be distributed on June 27, with the record and ex-dividend dates set for June 13. Despite this positive news, Gilead's shares saw a 3% decline after hours due to lowered 2025 diluted EPS guidance.
Key Takeaways
- Gilead Sciences maintains a quarterly dividend, yielding 2.98%.
- Shares dropped 3% following a decrease in 2025 EPS guidance.
- Analysts predict an average price target of $112.48, indicating potential upside.
Wall Street Analysts' Insights
Analyzing the one-year price targets from 24 experts, Gilead Sciences Inc (GILD, Financial) carries an average target price of $112.48. This includes a high estimate of $140.00 and a low estimate of $82.00, suggesting a potential upside of 5.96% from the current trading price of $106.15. To explore more detailed estimates, visit the Gilead Sciences Inc (GILD) Forecast page.
Brokerage Recommendations
The consensus from 30 brokerage firms rates Gilead Sciences Inc (GILD, Financial) at 2.1, which reflects an "Outperform" status. This rating is on a scale from 1 to 5, where 1 stands for Strong Buy, and 5 indicates Sell. This suggests a general optimism among analysts regarding the stock's future performance.
GF Value Estimate
According to GuruFocus' estimates, the projected GF Value for Gilead Sciences Inc (GILD, Financial) in one year stands at $80.51. This estimation implies a potential downside of 24.15% from the current price of $106.15. The GF Value represents what the stock should ideally trade at, considering historical multiples, prior growth performance, and future business projections. For more in-depth data, check out the Gilead Sciences Inc (GILD) Summary page.
Also check out: (Free Trial)
